| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.93▼ | 2.93▼ | 2.93▼ | 2.91▲ | 3.07▼ |
| MA10 | 2.88▼ | 2.88▼ | 2.89▼ | 2.95▼ | 3.01▼ |
| MA20 | 3.00▼ | 3.00▼ | 3.02▼ | 3.13▼ | 3.15▼ |
| MA50 | 3.21▼ | 3.22▼ | 3.23▼ | 2.96▼ | 3.04▼ |
| MA100 | 3.12▼ | 3.03▼ | 3.02▼ | 3.17▼ | 3.25▼ |
| MA200 | 3.16▼ | 3.30▼ | 3.30▼ | 3.09▼ | 48.71▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.001▼ | -0.006▼ | -0.039▼ | -0.018▼ |
| RSI | 35.264▼ | 35.695▼ | 35.539▼ | 44.262▼ | 48.098▼ |
| STOCH | 50.626 | 50.626 | 47.815 | 31.056 | 56.235 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -61.538 | -65.882 |
| CCI | -108.082▼ | -108.082▼ | -118.361▼ | -60.467 | -32.178 |
|
Wednesday, April 01, 2026 04:53 PM
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/04/26 | 2.92 | 2.99 | 2.8556 | 2.92 | 6,908 |
| 06/04/26 | 2.90 | 3.00 | 2.70 | 2.87 | 15,154 |
| 02/04/26 | 2.91 | 3.07 | 2.90 | 2.93 | 16,861 |
| 01/04/26 | 2.87 | 3.14 | 2.87 | 2.95 | 12,967 |
| 31/03/26 | 2.8313 | 2.9388 | 2.67 | 2.86 | 50,046 |
| 30/03/26 | 2.97 | 3.01 | 2.81 | 2.82 | 45,109 |
| 27/03/26 | 2.97 | 3.0452 | 2.93 | 2.98 | 8,310 |
| 26/03/26 | 3.03 | 3.07 | 2.8801 | 3.01 | 19,218 |
| 25/03/26 | 3.31 | 3.31 | 3.01 | 3.01 | 18,400 |
| 24/03/26 | 3.30 | 3.30 | 3.0699 | 3.14 | 18,771 |
|
|
||||
|
|
||||
|
|